BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14724935)

  • 1. [Lymphatic metastasis and VEGF-C expression in ovarian epithelial tumors].
    Ding MX; Li JC; Tang XH
    Shi Yan Sheng Wu Xue Bao; 2003 Dec; 36(6):445-52. PubMed ID: 14724935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of VEGF-C mRNA and CD 31 in esophageal squamous cell carcinoma].
    Ding MX; Li JC
    Shi Yan Sheng Wu Xue Bao; 2003 Aug; 36(4):269-74. PubMed ID: 14574989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of EGFR expression with angiogenesis and chemoresistance in ovarian carcinoma].
    Chen AP; Zhang J; Liu H; Zhao SP; Dai SZ; Sun XL
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):48-52. PubMed ID: 19538870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
    Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX; Wu Y; Han HQ; Wang QH
    Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
    Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
    Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between the expression of VEGF-C mRNA, VEGFR-3, CD31 and tumor metastases in Chinese with prostate cancer].
    Ding GF; Li JC; Xu YF; Sun Y; Tao L
    Shi Yan Sheng Wu Xue Bao; 2005 Jun; 38(3):257-64. PubMed ID: 16044920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma.
    Yokoyama Y; Charnock-Jones DS; Licence D; Yanaihara A; Hastings JM; Holland CM; Emoto M; Umemoto M; Sakamoto T; Sato S; Mizunuma H; Smith SK
    Br J Cancer; 2003 Jan; 88(2):237-44. PubMed ID: 12610509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance.
    Zhang W; Ling D; Tan J; Zhang J; Li L
    Oncol Rep; 2013 Feb; 29(2):637-45. PubMed ID: 23174953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
    Jennbacken K; Vallbo C; Wang W; Damber JE
    Prostate; 2005 Oct; 65(2):110-6. PubMed ID: 15880525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer].
    Hu CJ; Zhang F; Chen YJ; Sun XM; Zheng JF
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):520-3. PubMed ID: 19950700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer].
    Dong X; Qiu XS; Wang EH; Li QC; Gu W
    Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):128-32. PubMed ID: 12839674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma].
    Chen BY; Ye DF; Xie X; Chen HZ; Lü WG
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):33-7. PubMed ID: 15771796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
    Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary.
    Orre M; Rogers PA
    Int J Cancer; 1999 Apr; 84(2):101-8. PubMed ID: 10096239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
    Hu YQ; Liu YJ
    Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of VEGF-D in epithelial ovarian cancer and its relationship to lymphatic metastasis.
    He L; He J; Zhao X
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e161-6. PubMed ID: 23915006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].
    Tan XJ; Lang JH; Lou WZ; Shen K; Xu XY
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):274-8. PubMed ID: 18788631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.